Goodbye to the injection .. insulin tablets for diabetics

0
29


A competition between Indian and Israeli companies to produce it

Goodbye to the daily insulin injections that have long bothered diabetics, as the Oramid Pharmaceutical Company has begun final-stage tests for insulin tablets to be taken orally, instead of injections that help diabetics to maintain blood sugar levels at normal levels.

The Al-Hurra website quoted the Times of Israel newspaper that the Israeli drug company, Oramid, has actually started testing the final stage of the new oral insulin. The trials are being held in the United States under the supervision of the US Food and Drug Administration in California.

The newspaper quoted Auramid CEO Nadav Kidron: The new treatment will reduce costs for diabetics, and reduce complications as well, adding: “This drug has the potential to improve the lives of hundreds of millions of diabetics around the world.”

Although the Indian company Biocon is also working on a similar invention, its product has not reached advanced experiences yet, at a time when the Israeli company is seeking to start using the product on type 2 patients within 3 years.

Kidron added, “One of the benefits of oral insulin is overcoming needle phobia, but most importantly, the insulin is transported directly to the liver.” By transporting it to the liver, we stop the excessive production of glucose where production actually occurs. Normally, the injection goes into the bloodstream and deals with glucose there instead of stopping the production in the liver. ”

Diabetes is a chronic disease that occurs when the pancreas is unable to produce the insulin that regulates the level of sugar in the blood in sufficient quantities.

Goodbye to the injection .. insulin tablets for diabetics

Ayman Hassan Previously 2020-11-26

Goodbye to the daily insulin injections that have long bothered diabetics, as the Oramid Pharmaceutical Company has begun final-stage tests for insulin tablets to be taken orally, instead of injections that help diabetics to maintain blood sugar levels at normal levels.

The Al-Hurra website quoted the Times of Israel newspaper that the Israeli drug company, Oramid, has actually started testing the final stage of the new oral insulin. The trials are being held in the United States under the supervision of the US Food and Drug Administration in California.

The newspaper quoted Auramid CEO Nadav Kidron: The new treatment will reduce costs for diabetics, and reduce complications as well, adding: “This drug has the potential to improve the lives of hundreds of millions of diabetics around the world.”

Although the Indian company Biocon is also working on a similar invention, its product has not reached advanced experiences yet, at a time when the Israeli company is seeking to start using the product on type 2 patients within 3 years.

Kidron added, “One of the benefits of oral insulin is overcoming needle phobia, but most importantly, the insulin is transported directly to the liver.” By transporting it to the liver, we stop the excessive production of glucose where production actually occurs. Normally, the injection goes into the bloodstream and deals with glucose there instead of stopping the production in the liver. ”

Diabetes is a chronic disease that occurs when the pancreas is unable to produce enough insulin that regulates the level of sugar in the blood.

November 26, 2020 – Rabi` al-Akhir 11, 1442

01:12 PM


A competition between Indian and Israeli companies to produce it

Goodbye to the daily insulin injections that have long bothered diabetics, as the Oramid Pharmaceutical Company has begun final-stage tests for insulin tablets to be taken orally, instead of injections that help diabetics to maintain blood sugar levels at normal levels.

The Al-Hurra website quoted the Times of Israel newspaper that the Israeli drug company, Oramid, has actually started testing the final stage of the new oral insulin. The trials are being held in the United States under the supervision of the US Food and Drug Administration in California.

The newspaper quoted Auramid CEO Nadav Kidron: The new treatment will reduce costs for diabetics, and reduce complications as well, adding: “This drug has the potential to improve the lives of hundreds of millions of diabetics around the world.”

Although the Indian company Biocon is also working on a similar invention, its product has not reached advanced experiences yet, at a time when the Israeli company is seeking to start using the product on type 2 patients within 3 years.

Kidron added, “One of the benefits of oral insulin is overcoming needle phobia, but most importantly, the insulin is transported directly to the liver.” By transporting it to the liver, we stop the excessive production of glucose where production actually occurs. Normally, the injection goes into the bloodstream and deals with glucose there instead of stopping the production in the liver. ”

Diabetes is a chronic disease that occurs when the pancreas is unable to produce enough insulin that regulates the level of sugar in the blood.

Note: The content of this news was written by Sabaq electronic newspaper It does not express a point of view Egypt today Rather, it was transferred with its content as it is from Sabaq electronic newspaper We are not responsible for the content of the news and the custody of the previous source mentioned.

LEAVE A REPLY

Please enter your comment!
Please enter your name here